MedPath
NMPA Approval

Lornoxicam for Injection

国药准字H20249830

December 25, 2024

Drug Information

注射用氯诺昔康

注射剂

8mg(每瓶实装8.6mg)

化学药品

December 25, 2024

Company Information

Applicant Company

浙江省金华市东阳市六石街道科技孵化中心甘溪东街888-5号

Manufacturing Company

湖北省潜江市章华南路特1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氯诺昔康 - NMPA 批准文号 | MedPath